Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News Cellbricks Therapeutics raises 10 million euros for bio-printed tissues Cellbricks drives living implants towards the clinic. From tissue engineering to organs, the biotech start-up is scaling up.

Marc Nemitz 25.03.2026

News NRW.BANK invests in iDEL Therapeutics iDEL Therapeutics raises 9 million euros for new approaches in cancer therapy. The technology is designed to transport active substances specifically into cancer cells and reduce side effects.

Marc Nemitz 18.03.2026

News BioNTech founders leave the company BioNTech founders Uğur Şahin and Özlem Türeci are planning a new mRNA company. BioNTech is already looking for new management. Worried looks in Mainz and Marburg.

Marc Nemitz 10.03.2026

News Outpost Bio receives $3.5M pre-seed The deep-tech company Outpost Bio secures 3.5 million US dollars in pre-seed funding to systematically model the interaction between humans and the microbiome for the first time.

Marc Nemitz 02.03.2026

News Exciva receives 51 million euros Series B for Alzheimer's therapy Gimv and EQT Life Sciences lead financing round. Capital enables international Phase II study on Alzheimer's agitation.

Marc Nemitz 20.01.2026

News DISCO Pharmaceuticals signs license deal with Amgen Biotech deal. Surfaceome technology convinces pharmaceutical giant. DISCO licenses novel cancer target to Amgen.

Marc Nemitz 07.01.2026

News 5 million euros seed for Amplifold DNA origami for rapid tests. Amplifold increases the sensitivity of LFAs by up to 100-fold. The seed financing has now been completed.

Marc Nemitz 10.12.2025

News That's fat - € 7.3 million Series A for Melt&Marble EIC Fund, Beiersdorf and Valio invest. Melt&Marble starts the commercialization of its fermentation-based high-performance fats with € 7.3 million Series A.

Marc Nemitz 08.12.2025

News Qorium secures 22 million euros to bring cultivated leather to the mass market Investors focus on sustainable materials. The biotech from Maastricht wants to revolutionize the leather industry.

Marc Nemitz 11.11.2025

News Tubulis closes Series C round for 344 million euros Munich-based biotech Tubulis accelerates ADC development following strong clinical data. € Total Series C financing increases to € 344 million.

Marc Nemitz 04.11.2025

1
2
3
4